117 related articles for article (PubMed ID: 24662249)
1. Prevalence and determinants of parathyroid dysfunction in elderly patients on hemodialysis.
Lu JR; Yi Y; Tian J; Xiong CX; Wang XH; Hu J; Chen XF
Blood Purif; 2014; 37(2):119-24. PubMed ID: 24662249
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors of Parathyroid Dysfunction in Elderly Patients with Chronic Kidney Disease Undergoing Hemodialysis.
Li W; Zhang S
Adv Clin Exp Med; 2015; 24(6):1007-12. PubMed ID: 26771973
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.
Guh JY; Chen HC; Chuang HY; Huang SC; Chien LC; Lai YH
Am J Kidney Dis; 2002 Jun; 39(6):1245-54. PubMed ID: 12046038
[TBL] [Abstract][Full Text] [Related]
4. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of some nutritional parameters in hemodialysis patients over and below 65 years of age].
Bednarek-Skublewska A; Baranowicz-Gaszczyk I; Jóźwiak L; Dzik M; Majdan M; Ksiazek A
Pol Arch Med Wewn; 2005 May; 113(5):417-23. PubMed ID: 16479823
[TBL] [Abstract][Full Text] [Related]
6. Are we overconcerned about secondary hyperparathyroidism and underestimating the more common secondary hypoparathyroidism in our dialysis patients?
Jeloka T; Mali M; Jhamnani A; Konde S; Jadhav V
J Assoc Physicians India; 2012 Feb; 60():102-5. PubMed ID: 22715556
[TBL] [Abstract][Full Text] [Related]
7. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
8. Hypoparathyroidism potentiates cardiovascular complications through disturbed calcium metabolism: possible risk of vitamin D(3) analog administration in dialysis patients with end-stage renal disease.
Tsuchihashi K; Takizawa H; Torii T; Ikeda R; Nakahara N; Yuda S; Kobayashi N; Nakata T; Ura N; Shimamoto K
Nephron; 2000 Jan; 84(1):13-20. PubMed ID: 10644903
[TBL] [Abstract][Full Text] [Related]
9. The Study of Low Calcium Dialysate on Elderly Hemodialysis Patients with Secondary Hypoparathyroidism.
Lu JR; Yi Y; Xiong ZX; Cheng XF; Hu J; Hang HY; Cheng J; Peng W
Blood Purif; 2016; 42(1):3-8. PubMed ID: 26905433
[TBL] [Abstract][Full Text] [Related]
10. Intensified treatment of hyperphosphatemia associated with reduction in parathyroid hormone in patients on maintenance hemodialysis.
Chen L; He JX; Chen YY; Ling YS; Lin CH; Guan TJ
Ren Fail; 2018 Nov; 40(1):15-21. PubMed ID: 29295646
[TBL] [Abstract][Full Text] [Related]
11. Changes of serum calcium, phosphorus, and parathyroid hormone concentrations and ocular findings among patients undergoing hemodialysis.
Pakdel F; Samimagham H; Shafaroodi A; Sheikhvatan M
Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1142-8. PubMed ID: 22089771
[TBL] [Abstract][Full Text] [Related]
12. Age-related decline in serum parathyroid hormone in maintenance hemodialysis patients is independent of inflammation and dietary nutrient intake.
Mehrotra R; Supasyndh O; Berman N; Kaysen G; Hurst L; Leonardi M; Das D; Kopple JD
J Ren Nutr; 2004 Jul; 14(3):134-42. PubMed ID: 15232791
[TBL] [Abstract][Full Text] [Related]
13. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
Greenbaum LA; Benador N; Goldstein SL; Paredes A; Melnick JZ; Mattingly S; Amdahl M; Williams LA; Salusky IB
Am J Kidney Dis; 2007 Jun; 49(6):814-23. PubMed ID: 17533024
[TBL] [Abstract][Full Text] [Related]
14. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
15. Sevelamer hydrochloride improves hyperphosphatemia in hemodialysis patients with low bone turnover rate and low intact parathyroid hormone levels.
Kokuho T; Toya Y; Kawaguchi Y; Tamura K; Iwatsubo K; Dobashi Y; Nakazawa A; Takeda H; Iwatsubo M; Hirawa N; Yasuda G; Ohnishi T; Umemura S
Ther Apher Dial; 2007 Dec; 11(6):442-8. PubMed ID: 18028171
[TBL] [Abstract][Full Text] [Related]
16. Relationship between serum intact parathyroid hormone and pruritus in hemodialysis patients.
Makhlough A; Emadi N; Sedighi O; Khademloo M; Bicmohamadi AR
Iran J Kidney Dis; 2013 Jan; 7(1):42-6. PubMed ID: 23314141
[TBL] [Abstract][Full Text] [Related]
17. Effect of a dietitian-managed bone algorithm on serum phosphorus level in maintenance hemodialysis patients.
Blair D; Byham-Gray L; Sweet SJ; Denmark R; Parrott JS; Lewis E; McCaffrey S; Thomson S
J Ren Nutr; 2013 Mar; 23(2):98-105.e2. PubMed ID: 22800689
[TBL] [Abstract][Full Text] [Related]
18. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study.
Gu Y; Ding F; Chen N; Mei CL; Qian JQ; Wang XY; Shi W; Hou FF; Li XW; Wang M; Chen YP
Ren Fail; 2005; 27(2):205-12. PubMed ID: 15807187
[TBL] [Abstract][Full Text] [Related]
19. Relation between Calcium, Phosphorus, Calcium-Phosphorus Index and iPTH in Chronic Kidney Disease Patients.
Adhikary LP; Yadava SK; Pokharel A; Khadka D; Thakur R
J Nepal Health Res Counc; 2015; 13(29):50-3. PubMed ID: 26411713
[TBL] [Abstract][Full Text] [Related]
20. Effects of diabetes mellitus, age, and duration of dialysis on parathormone in chronic hemodialysis patients.
Nasri H; Kheiri S
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):608-13. PubMed ID: 18580021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
